Let’s start up with the current stock price of NeoGenomics Inc. (NEO), which is $10.35 to be very precise. Recently in News on November 21, 2022, RaDaR(R) Assay Demonstrates Clinical Potential for Detecting Disease Recurrence Across All Types of Early Breast Cancer, Including Triple Negative Disease. Data presented at this year’s San Antonio Breast Cancer Symposium builds on strong base of evidence supporting promise of RaDaR in helping prevent recurrence and improving outcomes. You can read further details here
NeoGenomics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $35.34 on 01/04/22, with the lowest value was $6.00 for the same time period, recorded on 10/24/22.
NeoGenomics Inc. (NEO) full year performance was -72.24%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, NeoGenomics Inc. shares are logging -72.88% during the 52-week period from high price, and 72.50% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $6.00 and $38.17.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 398714 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the NeoGenomics Inc. (NEO) recorded performance in the market was -69.67%, having the revenues showcasing -10.70% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.28B, as it employees total of 2000 workers.
The Analysts eye on NeoGenomics Inc. (NEO)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 9.39, with a change in the price was noted +1.11. In a similar fashion, NeoGenomics Inc. posted a movement of +12.01% for the period of last 100 days, recording 1,440,225 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for NEO is recording 0.53 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.53.
Technical rundown of NeoGenomics Inc. (NEO)
Raw Stochastic average of NeoGenomics Inc. in the period of last 50 days is set at 72.62%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 67.33%. In the last 20 days, the company’s Stochastic %K was 66.22% and its Stochastic %D was recorded 67.03%.
Considering, the past performance of NeoGenomics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -69.67%. Additionally, trading for the stock in the period of the last six months notably improved by 31.68%, alongside a downfall of -72.24% for the period of the last 12 months. The shares increased approximately by -6.92% in the 7-day charts and went down by 33.89% in the period of the last 30 days. Common stock shares were lifted by -10.70% during last recorded quarter.